Developing Immunotherapy As Legitimate Therapy for Patients With Prostate Cancer

被引：9

作者：

Small, Eric J. ^{[1
]}

Fong, Lawrence

机构：

[1] Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 07期

关键词：

VACCINE; SAFETY;

D O I：

10.1200/JCO.2009.26.3483

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1085 / 1087

页数：3

共 17 条

[1] Clinical safety of a viral vector based prostate cancer vaccine strategy [J].

Arlen, Philip M. ;

Skarupa, Lisa ;

Pazdur, Mary ;

Seetharam, Mahesh ;

Tsang, Kwong Y. ;

Grosenbach, Douglas W. ;

Feldman, Jarett ;

Poole, Diane J. ;

Litzinger, Mary ;

Steinberg, Seth M. ;

Jones, Elizabeth ;

Chen, Clara ;

Marte, Jennifer ;

Parnes, Howard ;

Wright, John ;

Dahut, William ;

Schlom, Jeffrey ;

Gulley, James L. .

JOURNAL OF UROLOGY, 2007, 178 (04) :1515-1520

[2] A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer [J].

Arlen, PM ;

Gulley, JL ;

Parker, C ;

Skarupa, L ;

Pazdur, M ;

Panicali, D ;

Beetham, P ;

Tsang, KY ;

Grosenbach, DW ;

Feldman, J ;

Steinberg, SM ;

Jones, E ;

Chen, C ;

Marte, J ;

Schlom, J ;

Dahut, W .

CLINICAL CANCER RESEARCH, 2006, 12 (04) :1260-1269

[3] Antiandrogen, vaccine and combination therapy in patients with nonmetastatic hormone refractory prostate cancer [J].

Arlen, PM ;

Gulley, JL ;

Todd, N ;

Lieberman, R ;

Steinberg, SM ;

Morin, S ;

Bastian, A ;

Marte, J ;

Tsang, KY ;

Beetham, P ;

Grosenbach, DW ;

Schlom, J ;

Dahut, W .

JOURNAL OF UROLOGY, 2005, 174 (02) :539-546

[4] Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer [J].

Gulley, J ;

Chen, AP ;

Dahut, W ;

Arlen, PM ;

Bastian, A ;

Steinberg, SM ;

Tsang, K ;

Panicali, D ;

Poole, D ;

Schlom, J ;

Hamilton, JM .

PROSTATE, 2002, 53 (02) :109-117

[5]

GULLEY J, CANC IMMUNOL IMMUNOT

[6] Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer [J].

Gulley, JL ;

Arlen, PM ;

Bastian, A ;

Morin, S ;

Marte, J ;

Beetham, P ;

Tsang, KY ;

Yokokawa, J ;

Hodge, JW ;

Ménard, C ;

Camphausen, K ;

Coleman, CN ;

Sullivan, F ;

Steinberg, SM ;

Schlom, J ;

Dahut, W .

CLINICAL CANCER RESEARCH, 2005, 11 (09) :3353-3362

[7] Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer [J].

Halabi, S ;

Small, EJ ;

Kantoff, PW ;

Kattan, MW ;

Kaplan, EB ;

Dawson, NA ;

Levine, EG ;

Blumenstein, BA ;

Vogelzang, NJ .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (07) :1232-1237

[8]

Hodge JW, 2003, CLIN CANCER RES, V9, P1837

[9] Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer [J].

Kantoff, Philip W. ;

Schuetz, Thomas J. ;

Blumenstein, Brent A. ;

Glode, L. Michael ;

Bilhartz, David L. ;

Wyand, Michael ;

Manson, Kelledy ;

Panicali, Dennis L. ;

Laus, Reiner ;

Schlom, Jeffrey ;

Dahut, William L. ;

Arlen, Philip M. ;

Gulley, James L. ;

Godfrey, Wayne R. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (07) :1099-1105

[10] Safety and Immunological Efficacy of a DNA Vaccine Encoding Prostatic Acid Phosphatase in Patients With Stage D0 Prostate Cancer [J].

McNeel, Douglas G. ;

Dunphy, Edward J. ;

Davies, James G. ;

Frye, Thomas P. ;

Johnson, Laura E. ;

Staab, Mary Jane ;

Horvath, Dorothea L. ;

Straus, Jane ;

Alberti, Dona ;

Marnocha, Rebecca ;

Liu, Glenn ;

Eickhoff, Jens C. ;

Wilding, George .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (25) :4047-4054

← 1 2 →